Lv11
76 积分 2024-06-17 加入
"Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers." Full Text Sources | C A S SciFinder Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers
1个月前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
1个月前
已完结
Perspectives on the use of machine learning for ADME prediction at AstraZeneca
1个月前
已完结
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
1个月前
已完结
Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection
1个月前
已完结
Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity
1个月前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
1个月前
已完结
Discovery of Novel Spirocyclic MAT2A Inhibitors Demonstrating High In Vivo Efficacy in MTAP-Null Xenograft Models
2个月前
已完结
FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
7个月前
已完结
皖公网安备34019202002308
